Glaxosmithkline Consumer shoots up on reporting 30% jump in Q2FY13 net profit

Glaxosmithkline Consumer Healthcare is currently trading at Rs 2685.00, up by 46.00 points or 1.74% from its previous closing of Rs 2639.00 on the BSE.

The scrip opened at Rs 2658.90 and has touched a high and low of Rs 2690.00 and Rs 2641.00 respectively. So far 1668 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 10 has touched a 52 week high of Rs 2939.85 on 26-Apr-2012 and a 52 week low of Rs 2179.00 on 18-Jul-2012.

Last one week high and low of the scrip stood at Rs 2710.00 and Rs 2621.55 respectively. The current market cap of the company is Rs 11111.07 crore.

The promoters holding in the company stood at 43.16% while Institutions and Non-Institutions held 31.66% and 25.18% respectively.

GlaxoSmithkline Consumer Healthcare’s net profit jumped by 29.27% at Rs 106.60 crore for second quarter ended June 30, 2012 as compared to Rs 82.46 crore for the quarter ended June 30, 2011. Total income of the company has increased by 14.16% to Rs 786.96 crore for the Q2FY13 from Rs 689.35 crore for the similar quarter of the previous year.

GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.